KPIs & Operating Metrics(New)
Biopharma Testing VolumeBreakdown Of AssetsClinical VolumeContractual ObligationsCost Of RevenueCost Of Revenue By SegmentDeferred RevenueEmployee StatisticsGross Margin %Gross Margin By Segment %Gross ProfitGross Profit By SegmentIncome Before Provision For Income TaxesNon Gaap ProfitabilityNon Gaap Profitability %Non Gaap Profitability AnnualNon Gaap Profitability Annual %Opex As A % Of RevenueOPEX BreakdownProperty And Equipment, NetRevenueRevenue By RegionRevenue By Region %Revenue By Region AnnualRevenue By Region Annual %Revenue By SegmentRevenue By Segment %Revenue By Segment AnnualRevenue By Segment Annual %
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Guardant Health (GH) Revenue (2017 - 2025)

Historic Revenue for Guardant Health (GH) over the last 9 years, with Q3 2025 value amounting to $265.2 million.

  • Guardant Health's Revenue rose 3850.09% to $265.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $902.6 million, marking a year-over-year increase of 3038.08%. This contributed to the annual value of $739.0 million for FY2024, which is 3104.33% up from last year.
  • Guardant Health's Revenue amounted to $265.2 million in Q3 2025, which was up 3850.09% from $232.1 million recorded in Q2 2025.
  • Over the past 5 years, Guardant Health's Revenue peaked at $265.2 million during Q3 2025, and registered a low of $78.7 million during Q1 2021.
  • Moreover, its 5-year median value for Revenue was $137.2 million (2023), whereas its average is $148.8 million.
  • The largest annual percentage gain for Guardant Health's Revenue in the last 5 years was 3884.22% (2021), contrasted with its biggest fall of 1652.35% (2021).
  • Guardant Health's Revenue (Quarter) stood at $108.1 million in 2021, then grew by 17.37% to $126.9 million in 2022, then increased by 22.19% to $155.1 million in 2023, then skyrocketed by 30.16% to $201.8 million in 2024, then skyrocketed by 31.41% to $265.2 million in 2025.
  • Its Revenue was $265.2 million in Q3 2025, compared to $232.1 million in Q2 2025 and $203.5 million in Q1 2025.